ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

Virus Program Report On Scientific Activities

August 8, 1975

NCI Grant Funding Payline To Begin At 16th Percentile In FY 2010

December 11, 2009

DeVita To continue Discussions On Expanded Chops Despite ACCC Coolness; Would Go To DRCCA Board

March 27, 1981

NCI Is Considering New Core Grants For Prostate, Breast Research Centers

April 19, 1991

Donald Berry To Step Down From Departmental Posts At MD Anderson

November 26, 2010

National Coalition for Cancer Research Formed To Support Reauthorization, l Research Budgets

April 19, 1985